GE HealthCare inks a 10-year Care Alliance with UCSF Health to expand advanced imaging, boost MR excellence and strengthen long-term revenue visibility.
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
GE HealthCare Technologies Inc. (GEHC) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
GE HealthCare unveils next-gen LOGIQ ultrasound systems with AI and Verisound Digital tech, targeting liver disease and faster workflows to boost diagnostic precision.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here is how GE HealthCare Technologies (GEHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
GEHC wins FDA clearance for three SIGNA MRI innovations, boosting AI-driven workflows, sustainability and precision imaging capabilities.
GE HealthCare expands its BARDA deal by $35M to speed AI-enabled ultrasound and next-gen imaging for trauma care and mass casualty readiness.
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
GE HealthCare launches ReadyFix in the United States, a remote fleet management tool for MAC VU360 ECGs to boost device uptime and efficiency across hospitals.
GE HealthCare and Diagnoly unite to embed AI fetal screening in Voluson ultrasounds, expanding FDA-cleared tools to drive software-led growth and differentiation.
GE HealthCare Technologies delivered strong Q4 2025 results, with revenue and adjusted EPS exceeding analyst expectations and robust segmental growth. GEHC remains a 'buy' as shares are attractively valued relative to peers, despite recent outperformance and an absolute valuation near fair value. Key growth drivers include the Imaging and Pharmaceutical Diagnostics segments, innovation in cloud-first imaging, and strategic acquisitions like Intelerad.